Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	252.75	178.96	170.28	185.31	154.34	98.38
Revenue Growth (YoY)	42.57%	5.10%	-8.11%	20.06%	56.88%	15.65%
Cost of Revenue	88.26	89.16	96.02	75.6	191.64	138.6
Gross Profit	164.49	89.8	74.26	109.71	-37.3	-40.22
Selling, General & Admin	162.87	157.57	172.51	184.13	169.97	110.89
Research & Development	78.12	85.87	101.65	124.07	-	-
Amortization of Goodwill & Intangibles	1.7	1.7	1.7	1.7	1.7	1.7
Operating Expenses	242.68	245.14	275.86	309.9	171.67	112.6
Operating Income	-78.19	-155.34	-201.61	-200.19	-208.97	-152.82
Interest Expense	-11.78	-11.58	-13.8	-4.24	-	-
Interest & Investment Income	6.69	6.33	6.35	4.8	8.9	7.36
EBT Excluding Unusual Items	-83.28	-160.6	-209.06	-199.63	-200.07	-145.45
Merger & Restructuring Charges	-7.21	-7.21	-	-	-	-
Gain (Loss) on Sale of Investments	3.68	8.21	9.18	-0.74	-7.23	-0.77
Asset Writedown	7.21	-	-25.43	-	-	-
Pretax Income	-79.6	-159.6	-225.3	-200.37	-207.3	-146.23
Earnings From Continuing Operations	-79.6	-159.6	-225.3	-200.37	-207.3	-146.23
Minority Interest in Earnings	-0.02	0.1	0.05	0.18	0.02	-
Net Income	-79.61	-159.49	-225.25	-200.19	-207.28	-146.23
Net Income to Common	-79.61	-159.49	-225.25	-200.19	-207.28	-146.23
Shares Outstanding (Basic)	150	147	144	143	140	131
Shares Outstanding (Diluted)	150	147	144	143	140	131
Shares Change (YoY)	2.70%	1.88%	1.31%	1.54%	6.96%	89.71%
EPS (Basic)	-0.53	-1.08	-1.56	-1.40	-1.48	-1.11
EPS (Diluted)	-0.53	-1.08	-1.56	-1.40	-1.48	-1.11
Free Cash Flow	-62.94	-98.88	-167.02	-200.29	-254.47	-168.49
Free Cash Flow Per Share	-0.42	-0.67	-1.16	-1.41	-1.81	-1.28
Gross Margin	65.08%	50.18%	43.61%	59.20%	-24.17%	-40.88%
Operating Margin	-30.93%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%
Profit Margin	-31.50%	-89.12%	-132.28%	-108.03%	-134.30%	-148.63%
Free Cash Flow Margin	-24.90%	-55.25%	-98.09%	-108.09%	-164.87%	-171.26%
EBITDA	-60.1	-136.09	-179.38	-179.27	-195.01	-144.35
EBITDA Margin	-23.78%	-76.05%	-105.34%	-96.74%	-126.35%	-146.72%
D&A For EBITDA	18.09	19.26	22.23	20.92	13.95	8.47
EBIT	-78.19	-155.34	-201.61	-200.19	-208.97	-152.82
EBIT Margin	-30.93%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%
Advertising Expenses	-	6.1	8.6	13.7	-	14.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.